Compare BOKF & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOKF | BRKR |
|---|---|---|
| Founded | 1910 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.7B |
| IPO Year | 2007 | 2000 |
| Metric | BOKF | BRKR |
|---|---|---|
| Price | $134.53 | $55.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $133.67 | $48.54 |
| AVG Volume (30 Days) | 249.2K | ★ 3.0M |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.91% | 0.58% |
| EPS Growth | ★ 12.65 | N/A |
| EPS | ★ 2.58 | 0.02 |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $6.56 | $6.30 |
| Revenue Next Year | $5.22 | $3.81 |
| P/E Ratio | ★ $51.50 | $2,826.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.89 | $28.53 |
| 52 Week High | $139.73 | $64.54 |
| Indicator | BOKF | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 56.62 |
| Support Level | $129.49 | $52.90 |
| Resistance Level | $136.59 | $64.54 |
| Average True Range (ATR) | 2.54 | 3.06 |
| MACD | 0.46 | -0.65 |
| Stochastic Oscillator | 84.74 | 21.35 |
BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.